Increased amnionic fluid alpha‐fetoprotein due to a holoacardium amorphous twin
- 23 April 1981
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 19 (4) , 257-261
- https://doi.org/10.1111/j.1399-0004.1981.tb00705.x
Abstract
Amnionic fluid alpha‐fetoprotein measurement was employed as a screening test for neural tube defects in a pregnancy only at risk due to advanced maternal age. The alpha‐fetoprotein concentration was elevated more than 10 standard deviations above the mean and was found to be caused by a holoacardium amorphous twin. A normal female fetus was also present. Various causes of elevated alpha‐fetoprotein concentration in amnionic fluid are discussed.Keywords
This publication has 4 references indexed in Scilit:
- TWIN FETUS PAPYRACEUS AND ALPHA-FETOPROTEIN: A CLINICAL DILEMMAThe Lancet, 1979
- CLINICAL DILEMMAS ARISING FROM THE ANTENATAL DIAGNOSIS OF NEURAL TUBE DEFECTSBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- FETAL PATHOPHYSIOLOGY OF HUMAN α‐FETOPROTEIN*Annals of the New York Academy of Sciences, 1975
- Alpha fetoprotein in maternal serum: A new marker for detection of fetal distress and intrauterine deathAmerican Journal of Obstetrics and Gynecology, 1973